Answers are grounded in this paper and cite their sources.
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease that manifests as vascular malformations in the brain, lung, liver, gastrointestinal tract, nasal mucosa, and skin. Diagnosis and management of HHT is guided in large part by imaging studies, making it a condition with which the radiology community needs familiarity. Proper screening and care lead to improved morbidity and mortality in patients with HHT. International guidelines were recently updated and form the basis for a detailed discussion of the role of imaging and image-guided therapy in HHT.
No takes yet. Share an insight, caveat, or question.
Hetts et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: